Real-Life Anemia Management Among Patients with Non-Dialysis-Dependent Chronic Kidney Disease in Three European Countries

Real-Life Anemia Management Among Patients with Non-Dialysis-Dependent Chronic Kidney Disease in Three European Countries

Danilo Fliser,1 Maria Mata Lorenzo,2 Katherine Houghton,3 Claire Ainsworth,3 Martin Blogg,2 Elena González de Antona Sánchez,4 Jose Portoles5 1Saarland University Medical Center, Homburg, Germany; 2Astellas Pharma Europe Ltd., Addlestone, UK; 3RTI Health Solutions, Manchester, UK; 4Astellas Pharma E...

Full description

Bibliographic Details
Main Authors:	Fliser D, Mata Lorenzo M, Houghton K, Ainsworth C, Blogg M, González de Antona Sánchez E, Portoles J
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-04-01
Series:	International Journal of Nephrology and Renovascular Disease
Subjects:	anemia chronic kidney disease clinical care process erythropoiesis-stimulating agents iron therapy real-life management
Online Access:	https://www.dovepress.com/real-life-anemia-management-among-patients-with-non-dialysis-dependent-peer-reviewed-fulltext-article-IJNRD

Similar Items

Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease
by: Tomas Ganz, et al.
Published: (2023-06-01)

Treatment Options for Anemia in Kidney Transplant Patients: A Review
by: Mario Bonomini, et al.
Published: (2023-08-01)

Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
by: Keiji Hirai, et al.
Published: (2021-07-01)

Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
by: Jose Portolés, et al.
Published: (2021-03-01)

Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States
by: Eric D. Weinhandl, et al.
Published: (2023-12-01)

Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
by: Keiji Hirai, et al.
Published: (2023-02-01)

Management of anemia in chronic kidney disease
by: S.V. Kushnirenko
Published: (2021-04-01)

Anemia of chronic diseases: the important aspects of pathogenesis and treatment
by: O. A. Rukavitsyn
Published: (2016-03-01)

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
by: Matti Aapro, et al.
Published: (2019-01-01)

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1
by: Alberto Martínez-Castelao, et al.
Published: (2015-03-01)

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1
by: Alberto Martínez-Castelao, et al.
Published: (2015-03-01)

Anemia associated with chronic heart failure: current concepts
by: Shah R, et al.
Published: (2013-02-01)

Darbepoetin in chronic kidney disease and dialysis patients; an updated review of outcomes
by: Tarun Kumar Jeloka, et al.
Published: (2020-05-01)

Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease
by: Mrittika Roy, et al.
Published: (2023-12-01)

Pathophysiology of anemia in chronic kidney diseases: A review
by: Josef Zadrazil, et al.
Published: (2015-06-01)

2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
by: Hiroyasu Yamamoto, et al.
Published: (2017-06-01)

Usefulness of mid-week hemoglobin measurement for anemia management in patients undergoing hemodialysis: a retrospective cohort study
by: Soo Ya Bae, et al.
Published: (2019-08-01)

Diagnostic evaluation and assessment of anemia in a patient with chronic kidney disease and gastrointestinal angioectasias undergoing hemodialysis
by: Karen Courville, et al.
Published: (2022-07-01)

Epidemiología y tratamiento de la anemia renal en España: estudio retrospectivo RIKAS
by: Aleix Cases, et al.
Published: (2023-09-01)

Research progress on treatment of renal anemia in patients with chronic kidney disease
by: Li Yudong, Liao Wenjian, Luo Yonghang, Chen Qiuyu, Su Yong
Published: (2023-05-01)

Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?
by: Oana Nicoleta Buliga-Finis, et al.
Published: (2023-06-01)

Hepcidin and Anemia: A Tight Relationship
by: Alessia Pagani, et al.
Published: (2019-10-01)

Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation
by: Yukiko Yasuoka, et al.
Published: (2020-06-01)

Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection
by: Yu S Milovanov, et al.
Published: (2016-06-01)

An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
by: Besarab Anatole, et al.
Published: (2012-08-01)

Effect of long period treatment with erythropoiesis stimulating agents on clinically and laboratory parameters in hemodialysis autosomal dominant polycystic kidney disease patients
by: Orăsan Olga Hilda, et al.
Published: (2017-10-01)

Aspectos no resueltos en el manejo de la anemia renal, un consenso Delphi del Grupo de Anemia de la S.E.N
by: José Portolés, et al.
Published: (2023-09-01)

Biomarkers of erythropoiesis response to intravenous iron in a crossover pilot study in unexplained anemia of the elderly
by: Justin J. Yoo, et al.
Published: (2023-12-01)

Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia
by: Yihang Li, et al.
Published: (2022-05-01)

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
by: Patrick Biggar, et al.
Published: (2017-09-01)

ESA, Iron Therapy and New Drugs: Are There New Perspectives in the Treatment of Anaemia?
by: Lucia Del Vecchio, et al.
Published: (2021-02-01)

Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis
by: Dinghua Chen, et al.
Published: (2023-05-01)

Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice
by: N. V. Zhukov
Published: (2022-11-01)

Hemoglobin and Clinical Outcomes in Hemodialysis: An Analysis of US Medicare Data From 2018 to 2020Plain-Language Summary
by: Eric W. Young, et al.
Published: (2023-02-01)

Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimiliars
by: Perrone V, et al.
Published: (2016-12-01)

Blood Transfusions in Dogs and Cats Receiving Hemodialysis: 230 Cases (June 1997–September 2012)
by: C. Langston, et al.
Published: (2017-03-01)

Temporal Trends in Hemoglobin, Use of Erythropoiesis Stimulating Agents, and Major Clinical Outcomes in Incident Dialysis Patients in Canada
by: Mark Canney, et al.
Published: (2021-04-01)

A possible contributor to erythropoiesis-stimulating agents requirement in hemodialysis: Paraoxonase 1 activity
by: Mehmet Kürşat Derici, et al.
Published: (2021-07-01)

Application of innovative hemocytometric parameters and algorithms for improvement of microcytic anemia discrimination
by: Margreet Schoorl, et al.
Published: (2015-06-01)

How to select appropriate hemoglobin target levels on health-related quality of life and outcomes for patients with chronic kidney disease?
by: Filippo Salvati
Published: (2013-12-01)